Review of donepezil, rivastigmine, galantamine and memantine for the treatment of dementia in Alzheimer's disease in adults with Down syndrome: implications for the intellectual disability population (Q35813930)
scientific article published on June 2004
Language:
Current Data About Review of donepezil, rivastigmine, galantamine and memantine for the treatment of dementia in Alzheimer's disease in adults with Down syndrome: implications for the intellectual disability population
(P31) (Q13442814)
(P248)
(P698) 15211527
(P813) Thursday, August 10, 2017

(P304) 509-515
(P248)
(P698) 15211527
(P813) Thursday, August 10, 2017

(P407) (Q1860)

(P433) 6
(P248)
(P698) 15211527
(P813) Thursday, August 10, 2017

(P478) 19
(P248)
(P698) 15211527
(P813) Thursday, August 10, 2017

(P577) Tuesday, June 1, 2004
(P248)
(P698) 15211527
(P813) Thursday, August 10, 2017

(P921) (Q12131)

(Q11081)

(Q47715)
(P887)

(Q183560)
(P887)

(Q83030)
(P887)

(Q3317827)
(P887)

(P1433) (Q6051406)
(P248)
(P698) 15211527
(P813) Thursday, August 10, 2017

(P1476) "Review of donepezil, rivastigmine, galantamine and memantine for the treatment of dementia in Alzheimer's disease in adults with Down syndrome: implications for the intellectual disability population" (language: en)
(P248)
(P698) 15211527
(P813) Thursday, August 10, 2017

(P2093) Prasher VP
(P1545) 1
(P248)
(P698) 15211527
(P813) Thursday, August 10, 2017

(P13046) (Q7318358)
(P248)

other details
description scientific article published on June 2004

External Links
(P356) 10.1002/GPS.1077
(P698) 15211527